It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
I'm volunteering with an organization ( www.treatearly.org... ) trying to inform the public (and doctors) about mismanagement of clinical trials for Hydroxychloroquine (HCQ). We've all seen independent doctors and their patients reporting remarkable success with HCQ in the field, while "official" clinical trials have of late turned largely negative. It appears nearly all of the clinical trials are using HCQ in a "salvage" role in hospitalized patients with advanced disease, rather than initializing therapy early where antivirals tend to work best.
HCQ (much like Tamiflu) work, not by killing virus but by inhibiting reproduction & exponential growth, giving precious time for a proper immune response to be developed. Neither is intended or will work as a salvage medication for the acutely ill. The misleading early data emerging from poorly done trials is threatening to totally destroy doctor & patient access to HCQ in the US.
originally posted by: 111DPKING111
a reply to: 111DPKING111
Andrew Weil(guy in the Arizona State video above) recommends you stop supplementing the following if symptomatic to avoid inflammation.
-Elderberry (Sambucus nigra)
-Isolated polysaccharide extracts from medicinal mushrooms
-Echinacea angustifolia and E. purpurea
-Larch arabinogalactan
-Vitamin D
DURING SYMPTOMS OF INFECTION OR POSITIVE TEST FOR COVID-19:
To Avoid: Given the integral role of inflammatory cytokines (namely IL-1B and IL-18) in the pathogenicity of COVID-19, as well as the impossibility of predicting which individuals are susceptible to the “cytokine storm”, technically called secondary hemophagocytic lymphohistiocytosis, or sHLH, it appears to be prudent to avoid high and regular use of immunostimulatory agents which increase these cytokines. Again, in the absence of human
clinical data, caution is warranted with the following immune activating agents due to preclinical evidence of increased IL-1B and/or IL-18 production in infected immune cells:
originally posted by: 111DPKING111
a reply to: tanstaafl
"The only thing I totally disagree with is his recommendation to STOP taking D... that is nonsense. D3 doesn't cause inflammation. Would love to hear his reasoning on that one."
He goes into more detail:
"DURING SYMPTOMS OF INFECTION OR POSITIVE TEST FOR COVID-19:
To Avoid: Given the integral role of inflammatory cytokines (namely IL-1B and IL-18) in the pathogenicity of COVID-19, as well as the impossibility of predicting which individuals are susceptible to the “cytokine storm”, technically called secondary hemophagocytic lymphohistiocytosis, or sHLH, it appears to be prudent to avoid high and regular use of immunostimulatory agents which increase these cytokines. Again, in the absence of human
clinical data, caution is warranted with the following immune activating agents due to preclinical evidence of increased IL-1B and/or IL-18 production in infected immune cells:
originally posted by: 111DPKING111
a reply to: tanstaafl
This only if you show symptoms, he is recommending D otherwise.
Vit D can be stored(the natural process would be to get extra in the summer so you have reserves year round), there is no harm going a few days without it if you get a fever.
Especially if it means you dont lose your lungs.
The Oxford scientists now say that with an emergency approval from regulators, the first few million doses of their vaccine could be available by September
Scientists at the National Institutes of Health’s Rocky Mountain Laboratory in Montana last month inoculated six rhesus macaque monkeys with single doses of the Oxford vaccine. The animals were then exposed to heavy quantities of the virus that is causing the pandemic — exposure that had consistently sickened other monkeys in the lab. But more than 28 days later all six were healthy, said Vincent Munster, the researcher who conducted the test.
However, zinc was associated with a 49% lower risk of either being transferred to hospice or dying, a 44% decreased chance of requiring invasive ventilation, and a 56% increased likelihood of being discharged from the hospital and released to home care.